Search research articles
Contact Us
Filters
Showing results (201-210 of 216) with videos related to
Page
of 22
Sort By:
The Journal of Infectious Diseases
|
August 2, 2013
Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions
Wen-Hung Chung, Shin-Ru Shih, Ching-Fen Chang, et al.
The Journal of Clinical Investigation
|
August 29, 2018
Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus
Man Lung Yeung, Lilong Jia, Cyril C Y Yip, et al.
The Lancet. Respiratory Medicine
|
October 16, 2021
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
Szu-Min Hsieh, Ming-Che Liu, Yen-Hsu Chen, et al.
Antimicrobial Agents and Chemotherapy
|
July 17, 2020
Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
Hui-Chen Hung, Yi-Yu Ke, Sheng Yu Huang, et al.
Nucleic Acids Research
|
October 30, 2014
A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cells
Kuo-Feng Weng, Chuan-Tien Hung, Po-Ting Hsieh, et al.
Emerging Microbes & Infections
|
June 17, 2020
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East
Yu-Nong Gong, Kuo-Chien Tsao, Mei-Jen Hsiao, et al.
Emerging Infectious Diseases
|
March 14, 2023
Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan
Pei-Lan Shao, Hsiao-Chen Tu, Yu-Nong Gong, et al.
Lancet (London, England)
|
April 15, 2022
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
Trong Toan Nguyen, Cheng-Hsun Chiu, Chien-Yu Lin, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 17, 2026
HLA-C-derived peptide MH-1 as an early-stage intervention against SARS-CoV-2 infection
Ting-Yan Jian, Sheng-Yu Huang, Chia-Yu Chang, et al.
Plos Pathogens
|
February 26, 2021
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
Kuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 216) with videos related to
Sort By:
Page
of 22
The Journal of Infectious Diseases
|
August 2, 2013
Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions
Wen-Hung Chung, Shin-Ru Shih, Ching-Fen Chang, et al.
The Journal of Clinical Investigation
|
August 29, 2018
Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus
Man Lung Yeung, Lilong Jia, Cyril C Y Yip, et al.
The Lancet. Respiratory Medicine
|
October 16, 2021
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
Szu-Min Hsieh, Ming-Che Liu, Yen-Hsu Chen, et al.
Antimicrobial Agents and Chemotherapy
|
July 17, 2020
Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
Hui-Chen Hung, Yi-Yu Ke, Sheng Yu Huang, et al.
Nucleic Acids Research
|
October 30, 2014
A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cells
Kuo-Feng Weng, Chuan-Tien Hung, Po-Ting Hsieh, et al.
Emerging Microbes & Infections
|
June 17, 2020
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East
Yu-Nong Gong, Kuo-Chien Tsao, Mei-Jen Hsiao, et al.
Emerging Infectious Diseases
|
March 14, 2023
Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan
Pei-Lan Shao, Hsiao-Chen Tu, Yu-Nong Gong, et al.
Lancet (London, England)
|
April 15, 2022
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
Trong Toan Nguyen, Cheng-Hsun Chiu, Chien-Yu Lin, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 17, 2026
HLA-C-derived peptide MH-1 as an early-stage intervention against SARS-CoV-2 infection
Ting-Yan Jian, Sheng-Yu Huang, Chia-Yu Chang, et al.
Plos Pathogens
|
February 26, 2021
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
Kuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.
Page
of 22